This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2nnp

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2nnp.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2nnp.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2nnp| PDB=2nnp | SCENE= }}
{{STRUCTURE_2nnp| PDB=2nnp | SCENE= }}
-
'''Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir'''
+
===Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir===
-
==Overview==
+
<!--
-
Saquinavir (SQV), the first antiviral HIV-1 protease (PR) inhibitor approved for AIDS therapy, has been studied in complexes with PR and the variants PR(I) (84V) and PR(V) (82A) containing the single mutations I84V and V82A that provide resistance to all the clinical inhibitors. Atomic resolution crystal structures (0.97-1.25 A) of the SQV complexes were analyzed in comparison to the protease complexes with darunavir, a new drug that targets resistant HIV, in order to understand the molecular basis of drug resistance. PR(I) (84V) and PR(V) (82A) complexes were obtained in both the space groups P2(1)2(1)2 and P2(1)2(1)2(1), which provided experimental limits for the conformational flexibility. The SQV interactions with PR were very similar in the mutant complexes, consistent with the similar inhibition constants. The mutation from bigger to smaller amino acids allows more space to accommodate the large group at P1' of SQV, unlike the reduced interactions observed in darunavir complexes. The residues 79-82 have adjusted to accommodate the large hydrophobic groups of SQV, suggesting that these residues are intrinsically flexible and their conformation depends more on the nature of the inhibitor than on the mutations in this region. This analysis will assist with development of more effective antiviral inhibitors.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17243183}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17243183 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17243183}}
==About this Structure==
==About this Structure==
Line 37: Line 41:
[[Category: Mutant]]
[[Category: Mutant]]
[[Category: Saquinavir]]
[[Category: Saquinavir]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 09:40:45 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 22:48:38 2008''

Revision as of 19:48, 27 July 2008

Image:2nnp.png

Template:STRUCTURE 2nnp

Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir

Template:ABSTRACT PUBMED 17243183

About this Structure

2NNP is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

Reference

Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir., Tie Y, Kovalevsky AY, Boross P, Wang YF, Ghosh AK, Tozser J, Harrison RW, Weber IT, Proteins. 2007 Apr 1;67(1):232-42. PMID:17243183

Page seeded by OCA on Sun Jul 27 22:48:38 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2nnp"
Personal tools